|Study Participants||Healthcare Professionals||Researchers||Locations||Publications||What is TrialNet?||News and Events||Get Screened!||Home|
Information for Study Participants
The Nutritional Intervention to Prevent Diabetes (NIP) Study
Status: No Longer Recruiting
To join this study, you must fulfill the conditions below:
About this Study
The Nutritional Intervention to Prevent Type 1 Diabetes Pilot Study (NIP) will help us learn more about a dietary substance, docosahexaenoic acid (DHA). DHA is a natural ingredient found in mother's breast milk and in various foods.
DHA is important for brain and eye development and has also helped people with autoimmune diseases that are similar to diabetes. Everyone gets some DHA in his or her diet, but we want to see if giving more DHA will do even more good. To test this idea, we would have to start early, well before the immune system begins its attack. We want to start before 6 months of age, even before birth. DHA can be found in fish, but the DHA in this pilot is taken from plant sources, so there's no need to worry about the bad effects of mercury or other toxic materials.
This research is being done as a pilot study, which is a test run - a small study of just 90 babies. The pilot study will not tell us if DHA will prevent type 1 diabetes, but it will tell us if it is possible to do a larger study.
What will I be asked to do?
If pregnant, you will take four capsules a day during your third trimester. If nursing, you will also be asked to take four capsules a day.
If your baby is on infant formula, you will be asked to use formula provided by the study. All study formula will contain some DHA.
You and your baby will need to make regular visits to the study site.
It is anticipated that babies will participate in the study for at least 1 year
To see if you might be eligible for this study and for a referral to a TrialNet site:
Information will be kept confidential.